The present invention relates generally to Apo2L/TRAIL purification involving crystallization.

 
Web www.patentalert.com

< Histone demethylation mediated by the nuclear amine oxidase homolog LSD1

< ApO2 ligand/TRAIL formulations

> Transcutaneous analyte sensor

> Antidepressant
~ 00618